$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
AstraZeneca And Amgen''s Tezspire Approved In US For Severe Asthma
07:33am, Monday, 20'th Dec 2021 Business Insider Markets
(RTTNews) - AstraZeneca (AZN.L, AZN) and Amgen''s Tezspire or tezepelumab-ekko has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged 12 years and older with severe asthma. AstraZeneca noted that Tezspire was approved following a Priority Review by the US Food and Drug Administration (FDA) and
Nanopharmaceuticals Market See Incredible Growth 2021-2028 | Abbott, GlaxoSmithKline and plc., Eli Lilly and Company, Astrazeneca plc.
05:46am, Monday, 20'th Dec 2021 OpenPR
The Nanopharmaceuticals Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Nanopharmaceuticals Market report is to supply an in-depth view and strategic
AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma
05:19am, Monday, 20'th Dec 2021
The FDA has approved AstraZeneca plc (NASDAQ: AZN) / Amgen Inc's (NASDAQ: AMGN) Tezspire (tezepelumab-ekko) as add-on maintenance treatment of adult and pediatric patients aged 12 years and older
AstraZeneca's lupus treatment Saphnelo recommended for approval in the EU
03:46am, Monday, 20'th Dec 2021
AstraZeneca PLC (LSE:AZN)'s Saphnelo (anifrolumab) therapy has been recommended for marketing authorisation in the European Union (EU) as treatment of adult patients with moderate to severe systemic
AstraZeneca and Amgen's Tezspire approved in US for severe asthma
03:29am, Monday, 20'th Dec 2021
AstraZeneca PLC (LSE:AZN) said its Tezspire drug, developed in collaboration with Amgen, Inc, has been approved in the US for treatment of severe asthma in patients older than 12 years. Tezspire (te
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
05:54pm, Sunday, 19'th Dec 2021 Benzinga
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some positive stock-specific news. Among the regulatory decisions for the week, the Food and Drug Administration gave the green light to argenx SE''s (NASDAQ: ARGX ) efgartigimod for the treatment of generalized myasthenia gravis. AstraZeneca plc (NASDAQ: AZN ) and Amgen, Inc. (NASDAQ: AMGN ) announced an FDA nod for their Tezspire as a treatment option for severe asthma for those aged 12 years and older. Bristol-Myers Squibb Company ''s (NYSE: BMY ) Orencia was approved for the prophylactic treatment of acute graft-versus-host disease. Calliditas Therapeutics AB (publ) (NASDAQ: CALT ) scored an FDA win for Tarpeyo, the first-approved treatment to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. Galera Therapeutics, Inc. (NASDAQ: Full story available on Benzinga.
Sinopharm anti-body response declines fastest : Study
03:53pm, Sunday, 19'th Dec 2021 Sri Lanka Mirror
Sinopharm vaccine have the least antibody response after three months compare to other vaccines, the latest antibody response for vaccines study done by a Sri Lankan research team shows. An antibody response research done by the Allergy Immunology and Cell Biology unit of University of Sri Jayewardenepura has shown that the antibody response was seen highest in the Moderna vaccine followed by Sputnik V, AstraZeneca, Sputink V light (first dose then) and then Sinopharm. The ACE2 blocking antibody levels were highest to lowest was Moderna > Sputnik V/ Oxford AstraZeneca (had equal levels)> first dose of Sputnik V (Sputnik light) > Sinopharm, the study said. Sinopharm is the most widely used vaccine in Sri Lanka which is generally believed to have contributed to lower levels of hospitalization and deaths, but its usefulness declines over time faster than others used in the country. In Sri Lanka recipients of all vaccines are being urged to get the Pfizer as a third booster which the government has made available.
Good Life Advisors LLC Invests $401,000 in AstraZeneca PLC (NASDAQ:AZN)
01:28pm, Sunday, 19'th Dec 2021 Transcript Daily
Good Life Advisors LLC bought a new position in AstraZeneca PLC (NASDAQ:AZN) during the 3rd quarter, HoldingsChannel reports. The fund bought 6,682 shares of the companys stock, valued at approximately $401,000. Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Pinnacle Wealth Planning Services Inc. grew its []
Huntington National Bank Buys 597 Shares of AstraZeneca PLC (NASDAQ:AZN)
12:54pm, Sunday, 19'th Dec 2021 Transcript Daily
Huntington National Bank lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN) by 16.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,164 shares of the companys stock after purchasing an additional 597 shares during the period. Huntington National Banks []
PH receives addl 1M Moderna vax doses from Germany
12:17pm, Sunday, 19'th Dec 2021 Philippine Canadian Inquirer
MANILA A total of 1,062,100 doses of the Moderna Covid-19 vaccine donated by the German government through the COVAX Facility arrived Sunday afternoon. Later, another 535,300 doses will be delivered at about 10:15 p.m., also via Singapore Airlines, to complete 1,597,400 donated doses while private-sector procured 663,400 doses of AstraZeneca jabs will arrive at 7:30 []
600 Shares in AstraZeneca PLC (NASDAQ:AZN) Bought by Emfo LLC
09:58am, Sunday, 19'th Dec 2021 Dakota Financial News
Emfo LLC acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN) in the third quarter, HoldingsChannel reports. The fund acquired 600 shares of the companys stock, valued at approximately $36,000. Several other institutional investors also recently made changes to their positions in the stock. Calamos Advisors LLC acquired a new stake in shares of []
Citigroup Reiterates Buy Rating for AstraZeneca (LON:AZN)
07:34am, Sunday, 19'th Dec 2021 Transcript Daily
Citigroup reiterated their buy rating on shares of AstraZeneca (LON:AZN) in a report issued on Thursday, Analyst Ratings Network reports. They currently have a £105 ($138.76) price target on the biopharmaceutical companys stock. Several other research firms have also recently commented on AZN. Jefferies Financial Group set a GBX 9,100 ($120.26) price target on AstraZeneca []
UK reaffirms support for arbitral ruling favoring PH in maritime dispute
06:59am, Sunday, 19'th Dec 2021 Manila Bulletin News
The United Kingdom (UK) has reaffirmed its support in upholding the 2016 arbitral ruling that favored the Philippines in its maritime dispute with China in the South China Sea. DFA Secretary Teodoro Locsin Jr. and UK Foreign and Commonwealth Development Office (FCDO) Minister of State for Asia and Pacific Amanda Milling meet at the sidelines of the G7-ASEAN Foreign and Development Ministers Meeting in Liverpool, UK on Dec. 11, 2021 to reaffirm the two nations enhanced partnership. (Photo courtesy of the DFA) Amanda Milling, UK Foreign and Commonwealth Development Office (FCDO) Minister of State for Asia and Pacific, during a meeting with Department of Foreign (DFA) Affairs Secretary Teodoro Locsin Jr., noted that weve consistently said that everyone needs to abide by the 2016 Arbitral Award. This developed after Locsin welcomed Millings earlier pronouncement reaffirming the importance the UK attaches to United Nations Convention on the Law of the Sea (UNCLOS) and a stable South China Sea and expressing concern at recent incidents that have raised tensions and urge against actions that hinder the peaceful settlement of disputes. Philippine supply boats were recently blocked and water cannoned by Chinese Coast Guard vessels in Ayungin Shoal, an act deemed illegal by the DFA.
Canada sends 55,000 AstraZeneca vaccines for Guyana
10:45am, Saturday, 18'th Dec 2021 Inews Guyana
Another tranche of 55,000 AstraZeneca vaccines on Friday arrived in Guyana, adding more resources to continue the vaccination campaign in the wake of COVID-19. This shipment of vaccines is a donation from the Government of Canada through the Pan American Health Organisation (PAHO) Revolving Funds. Advisor to the Health Minister, Dr Leslie Ramsammy was joined by []
Canada donates 55,000 doses of AstraZeneca vaccine for Guyana
07:02am, Saturday, 18'th Dec 2021 Guyana Times
Another tranche of 55,000 AstraZeneca vaccines on Friday arrived in Guyana, adding more resources to continue the vaccination campaign in the wake of COVID-19. This shipment of vaccines is a donation from the Government of Canada through the Pan American Health Organisation (PAHO) Revolving Funds. Advisor to the Health Minister, Dr Leslie Ramsammy was joined by [] The post Canada donates 55,000 doses of AstraZeneca vaccine for Guyana appeared first on Guyana Times .
Sign In
Buy AZN